Bora Pharmaceuticals Email Format
Pharmaceutical ManufacturingTaipei City, Taiwan501-1000 Employees
Bora Pharmaceuticals is an international contract development and manufacturing organization based in Neihu, Taipei City, Taiwan. It specializes in manufacturing a wide range of dosage forms—including complex oral solids, liquids, semi-solids, ophthalmics, biologics, and sterile injectables—from early clinical material through to commercial supply, with full packaging capabilities. The company operates ten CGMP facilities across Asia and North America, serving biopharma companies in more than 100 markets worldwide. In 2026 it expanded its U.S. footprint by acquiring MacroGenics' GMP drug substance manufacturing operations in Maryland and integrating related facilities in Rockville and Frederick. That year Bora was also recognized as a TIME World's Most Impactful Companies 500.